Results 121 to 130 of about 223,855 (315)
The Pharmaceutical Distribution Industry in China [PDF]
, 2020 This research explains the Chinese drug policy reform, specifically the drug supply or the distribution process to health care facilities. Secondary materials such as books, online articles, and journals were used to source for information during the ...
David, Ebenezer
core
European Journal of Pharmaceutical Sciences, 2016 Christoph, Saal, René, Holm
openaire +2 more sources
Bioprinting High‐Cell‐Density Cardiac Tissue Constructs With Sustained Contractile Function
Advanced Healthcare Materials, EarlyView.Contractile cardiomyocytes in 3D culture provide insights into the behavior of the heart. Combining a 3D bioprinting approach with a multi‐electrode array allows the development of the 3D culture to be monitored over time, and matured cultures allow the effect of drugs on cardiac function to be modelled, replicating effects seen in clinical application.
Priscila Melo +8 more
wiley +1 more source
Explaining Pharmaceutical R&D Growth Rates at the Industry Level: New Perspectives and Insights [PDF]
This paper uses aggregate data for the major pharmaceutical companies in the U.S. to study the rate of growth in pharmaceutical R&D intensity over the period from 1952 to 2001.
Santerre, Rexford +2 more
core +1 more source
Advanced Healthcare Materials, EarlyView.A heart‐on‐a‐chip model of dilated cardiomyopathy is developed from patient‐derived induced pluripotent stem cells. The model recapitulates key disease phenotypes and enables functional assessment through integrated bead‐based tracking and pillar deflection measurements.
Ali Mousavi +10 more
wiley +1 more source
The Impact of Patenting on New Product Introductions in the Pharmaceutical Industry [PDF]
Since Comanor and Scherer (1969), researchers have been using patents as a proxy for new product development. In this paper, we reevaluate this relationship by using novel new data.
Higgins, Matthew, Stuart, Graham
core +1 more source
The Value of Failures in Pharmaceutical R&D [PDF]
, 2012 We build a cumulative innovation model in which both success and failure provide valuable information for future research. To test this learning mechanism, we use a dataset covering outcomes of world-wide R&D projects in the pharmaceutical industry, and ...
Magazzini, Laura +3 more
core
Concise Synthesis of Lacosamide with High Chiral Purity
ACS Omega, 2019 Meng-Di Chen +7 more
doaj +1 more source
Advanced Healthcare Materials, EarlyView.(A) Isolation and purification of LDNVs. (B) Establishment of the ALI model and LDNVs delivery. (C) Therapeutic mechanisms of LDNVs in treating ALI. This scheme figure was drawn by Figdraw, ID: IUIIO21222. ABSTRACT Acute lung injury (ALI) is a lethal respiratory disease.
Xi Lin +10 more
wiley +1 more source
Beyond Philanthropy: The pharmaceutical industry, corporate social responsibility and the developing world [PDF]
, 2002 Every year, infectious diseases kill 14 million people worldwide. Most of these deaths are of poor people living in developing countries, particularly children under the age of five.
Bluestone, Ken +2 more
core